UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date
of report (Date of earliest event reported): March 4, 2010
Inverness Medical Innovations, Inc.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
001-16789
|
|
04-3565120 |
|
|
|
|
|
|
| (State or other jurisdiction
|
|
(Commission file number)
|
|
(IRS Employer |
| of incorporation)
|
|
|
|
Identification No.) |
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453
(Address of principal executive offices)
Registrant’s telephone number, including area code: (781) 647-3900
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.142-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 9.01 Financial Statements and Exhibits.
(b) Pro Forma Financial Information
In connection with the Registration Statement on Form S-4 (File No. 333-164897) (as amended from
time to time, the “Registration Statement”) of Inverness Medical Innovations, Inc. (the “Company”),
the Company is providing an unaudited pro forma condensed combined statement of operations of the
Company for the year ended December 31, 2009, giving pro forma effect to the Company’s acquisition
of the second territory business of ACON Laboratories, Inc., AZURE Institute, Inc., Oakville Hong
Kong Co., Ltd., and ACON Biotech (Hangzhou) Co., Ltd. (the “ACON Second Territory Business”) on
April 30, 2009, which is attached hereto as Exhibit 99.1 and incorporated by reference herein and
in the Registration Statement.
(d) Exhibits
| |
|
|
| Exhibit No. |
|
Description |
| |
99.1*
|
|
Unaudited pro forma condensed combined statement of operations
of the Company for the year ended December 31, 2009 giving pro
forma effect to the acquisition of the ACON Second Territory
Business on April 30, 2009 |